Epidemiological Study on Gout and the risk of Benign Prostatic Hyperplasia

碩士 === 高雄醫學大學 === 醫學研究所碩士班 === 105 === Objective: To evaluated the association between gout and the risk of benign prostatic hyperplasia among men by applying data Taiwan’s National Health Insurance Research Database (NHIRD) Methods: Population-based representative insurance (outpatient and inpatien...

Full description

Bibliographic Details
Main Authors: Nelly Pasaribu, 潘晨欣
Other Authors: Hung-Yi Chuang
Format: Others
Language:en_US
Published: 2017
Online Access:http://ndltd.ncl.edu.tw/handle/80625338348059596802
id ndltd-TW-105KMC05534019
record_format oai_dc
spelling ndltd-TW-105KMC055340192017-09-24T04:41:09Z http://ndltd.ncl.edu.tw/handle/80625338348059596802 Epidemiological Study on Gout and the risk of Benign Prostatic Hyperplasia 流行病學研究探討痛風與良性攝護腺肥大的風險 Nelly Pasaribu 潘晨欣 碩士 高雄醫學大學 醫學研究所碩士班 105 Objective: To evaluated the association between gout and the risk of benign prostatic hyperplasia among men by applying data Taiwan’s National Health Insurance Research Database (NHIRD) Methods: Population-based representative insurance (outpatient and inpatient) claims data of 29269 patients with gout and 29269 controls without gout (1:1, case: control ratio) between 1997 and 2010 in Taiwan were identified. The relation between gout and benign prostatic hyperplasia was evaluated using the Cox proportional hazards model. Moreover, association of early onset gout with benign prostatic hyperplasia and association of gout phenotypes with benign prostatic hyperplasia were estimated. Results: In total, 4418 (15.09%) patients with gout and 3847 (13.14%) controls developed benign prostatic hyperplasia in the follow-up period. Multivariate analyses revealed a significant association between gout and benign prostatic hyperplasia. Compared with the control group, the adjusted hazard ratios[HR] (95% confidence intervals [CIs]) for benign prostatic hyperplasia were 1.30 (1.24-1.36). The gout to benign prostatic hyperplasia association was modified by age (P interaction<0.0001), and it was significant in adults with age 20-40 years (adjusted HR=2.74, P<0.0001) and 40-60 years (adjusted HR=1.39, P<0.0001), but not in age>60 years (adjusted HR=1.07, P=0.063). Moreover, compared with gouty tophi, a significantly higher risk of benign prostatic hyperplasia was noted in gouty nephropathy (adjusted HR=1.24, 95% CI=1.08-1.44) Conclusion: Our results suggest that male gout is positively related to benign prostatic hyperplasia, particularly in gout patients younger than 40 years and gouty nephropathy. Keywords: Retrospective cohort study; Gout; Age; Benign prostatic hyperplasia Hung-Yi Chuang 莊弘毅 2017 學位論文 ; thesis 36 en_US
collection NDLTD
language en_US
format Others
sources NDLTD
description 碩士 === 高雄醫學大學 === 醫學研究所碩士班 === 105 === Objective: To evaluated the association between gout and the risk of benign prostatic hyperplasia among men by applying data Taiwan’s National Health Insurance Research Database (NHIRD) Methods: Population-based representative insurance (outpatient and inpatient) claims data of 29269 patients with gout and 29269 controls without gout (1:1, case: control ratio) between 1997 and 2010 in Taiwan were identified. The relation between gout and benign prostatic hyperplasia was evaluated using the Cox proportional hazards model. Moreover, association of early onset gout with benign prostatic hyperplasia and association of gout phenotypes with benign prostatic hyperplasia were estimated. Results: In total, 4418 (15.09%) patients with gout and 3847 (13.14%) controls developed benign prostatic hyperplasia in the follow-up period. Multivariate analyses revealed a significant association between gout and benign prostatic hyperplasia. Compared with the control group, the adjusted hazard ratios[HR] (95% confidence intervals [CIs]) for benign prostatic hyperplasia were 1.30 (1.24-1.36). The gout to benign prostatic hyperplasia association was modified by age (P interaction<0.0001), and it was significant in adults with age 20-40 years (adjusted HR=2.74, P<0.0001) and 40-60 years (adjusted HR=1.39, P<0.0001), but not in age>60 years (adjusted HR=1.07, P=0.063). Moreover, compared with gouty tophi, a significantly higher risk of benign prostatic hyperplasia was noted in gouty nephropathy (adjusted HR=1.24, 95% CI=1.08-1.44) Conclusion: Our results suggest that male gout is positively related to benign prostatic hyperplasia, particularly in gout patients younger than 40 years and gouty nephropathy. Keywords: Retrospective cohort study; Gout; Age; Benign prostatic hyperplasia
author2 Hung-Yi Chuang
author_facet Hung-Yi Chuang
Nelly Pasaribu
潘晨欣
author Nelly Pasaribu
潘晨欣
spellingShingle Nelly Pasaribu
潘晨欣
Epidemiological Study on Gout and the risk of Benign Prostatic Hyperplasia
author_sort Nelly Pasaribu
title Epidemiological Study on Gout and the risk of Benign Prostatic Hyperplasia
title_short Epidemiological Study on Gout and the risk of Benign Prostatic Hyperplasia
title_full Epidemiological Study on Gout and the risk of Benign Prostatic Hyperplasia
title_fullStr Epidemiological Study on Gout and the risk of Benign Prostatic Hyperplasia
title_full_unstemmed Epidemiological Study on Gout and the risk of Benign Prostatic Hyperplasia
title_sort epidemiological study on gout and the risk of benign prostatic hyperplasia
publishDate 2017
url http://ndltd.ncl.edu.tw/handle/80625338348059596802
work_keys_str_mv AT nellypasaribu epidemiologicalstudyongoutandtheriskofbenignprostatichyperplasia
AT pānchénxīn epidemiologicalstudyongoutandtheriskofbenignprostatichyperplasia
AT nellypasaribu liúxíngbìngxuéyánjiūtàntǎotòngfēngyǔliángxìngshèhùxiànféidàdefēngxiǎn
AT pānchénxīn liúxíngbìngxuéyánjiūtàntǎotòngfēngyǔliángxìngshèhùxiànféidàdefēngxiǎn
_version_ 1718540572748152832